Suneer Jain
I am a driven, educated, and enthusiastic scientist that believes in the healing of molecular medicine. Over the past several years, my career has afforded me the opportunity to work with some of the nation’s most foremost experts in the fields of molecular medicine, sequencing, and cell technology. I have worked on a number of exciting and innovative projects and was part of the team that established the Illumina Clinical Services Laboratory and worked to successfully sequence the first whole human genome in a CLIA-certified, CAP-accredited laboratory.
Wendy Russell
Prof Jeroen Raes
Prof. Jeroen Raes (m) is associate professor at KU Leuven since 2013 and VIB group leader since 2009. His group currently consists of 16 scientists, with expertise in bioinformatics, systems biology, clinical research and microbiology. He has a substantial track record in microbiome research and has been pioneering the analysis and integration of meta-omics datasets (metagenomics, metatranscriptomics, metaproteomics, meta-metabolomics) with environmental, clinical, host omics and dietary data.
He was involved in the FP7 MetaHIT and NIH Human Microbiome Project (the latter as only European partner), which laid the foundations for the human microbiome field as it is today. Finally, his lab is performing a wide range of disease-related projects in a.o. IDB, diabetes, cancer, IBS and antibiotics resistance on national (FWO/IWT) funding and develops novel approaches and tools for microbiome research.
Jeroen Raes coordinates the Flemish Gut Flora project, a large scale microbiome- focused population cohort in Belgium, and is bioinformatics coordinator in the Tara Oceans project performing large-scale meta-omics analysis of plankton communities.
Eran Segal
Ariel Cohen
Dr. Ariel Cohen is Director of Business Development and Alliances at BiomX, a microbiome drug discovery company. Prior to his role in BiomX, Dr. Cohen co-founded two biotech companies: OnTimeBio (Diagnostics) and Ensof Biosystems (Target discovery) and managed development of three academic discoveries to drug development companies. Dr. Cohen held business development roles at Integra Holdings, Yissum (Hebrew University’s Tech Transfer Office), and Aurum Ventures MKI. Prior to that Dr. Cohen served as Senior Project Manager at Evogene (NYSE:EVGN) an agriculture biotechnology company. Dr. Cohen holds a Ph.D. in Systems Biology and an M.Sc. in Computational Biology from the Weizmann Institute of Science and has published in top peer-reviewed journals, including; Science, Nature and Cell.
